Multidisciplinary management of cardiovascular disease in women: Delphi consensus

José M Gámez1,2, Milagros Pedreira Pérez3, María Rosa Fernández Olmo4

  • 1Servicio de Cardiología, Hospital Universitario Son Llatzer, Departamento de Medicina, Universidad de las Islas Baleares, Palma de Mallorca, Spain.

Insights

Expert consensus highlights the need for tailored cardiovascular disease (CVD) management in women, addressing risk factors, diagnosis, and treatment disparities. Further research and training are needed to reduce inequalities in women's heart health.

Area of Science:

  • Cardiology
  • Women's Health
  • Public Health

Background:

  • Current cardiovascular disease (CVD) clinical guidelines lack specific recommendations for the female population.
  • Expert consensus is needed to address the management of CVD in women.

Purpose of the Study:

  • To determine expert opinions on the management of cardiovascular disease (CVD) in women.
  • To identify areas of agreement and disagreement regarding CVD in women.

Main Methods:

  • A Delphi consensus method was employed with 31 cardiologists, 9 gynecologists/obstetricians, and 14 primary care physicians.
  • Experts evaluated 44 items related to CVD in women, categorized into risk factors/prevention, diagnosis/manifestations, and treatment/follow-up.

Main Results:

  • Consensus was reached on 27 out of 44 items (61.4%).
  • Key agreements included monitoring blood pressure during pregnancy for hypertensive disorders and controlling gestational diabetes.
  • Panelists agreed on lower statin intensity for women than men, but consensus on differential drug efficacy was lacking.

Conclusions:

  • High consensus indicates awareness of sex-based differences in CVD management and the need for interventions.
  • Low consensus, particularly in treatment and follow-up, highlights knowledge gaps and the need for further education and training.
Abstract

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
338
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.8K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.5K
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
573
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
181
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K